Drummond G R, Selemidis S, Cocks T M
Department of Pharmacology, Tri-radiate Building, University of Melbourne, Victoria 3010, Australia.
Br J Pharmacol. 2000 Feb;129(4):811-9. doi: 10.1038/sj.bjp.0703107.
Since cytochrome P(450)-derived metabolites of arachidonic acid and K(+) have been implicated in endothelium-derived hyperpolarizing factor (EDHF)-dependent responses, the aim of this study was to determine whether such factors contribute to non-nitric oxide (NO), endothelium-dependent relaxation to bradykinin (BK) in bovine isolated coronary artery. In rings of artery contracted with U46619 and treated with indomethacin (3 microM) and N(G)-nitro-L-arginine (L-NOARG; 100 microM), relaxation to BK (0.01 nM-0.3 microM) was blocked by approximately 60% after inhibition of K(+) channels with either high extracellular K(+) (high K(+); 15 - 67 mM) or apamin (0.3 microM). Ouabain (1 microM), an inhibitor of Na(+)/K(+)-ATPase, decreased the sensitivity to BK without affecting the maximum response. In L-NOARG-treated rings, ouabain had no further effect on the relaxation to BK. An inhibitor of inward-rectifying K(+) channels, Ba(2+) (30 microM), had no effect on relaxations to BK in the absence or presence of either L-NOARG or ouabain. KCl (2.5 - 10 mM) elicited small relaxations ( approximately 20%) that were abolished by nifedipine (0.3 microM) and ouabain. Both the high K(+)/apamin-sensitive relaxation to BK, and the relaxation to the K(ATP) channel-opener, levcromakalim (0.6 microM), were unaffected by the cytochrome P(450) inhibitor, 7-ethoxyresorufin (10 microM), or by co-treatment with a phospholipase A(2) inhibitor, arachidonyl trifluoromethyl ketone (AACOCF(3); 3 microM) and a diacylglycerol (DAG)-lipase inhibitor, 1, 6-bis-(cyclohexyloximinocarbonylamino)-hexane (RHC 80267; 30 microM). The non-NO/high K(+)-insensitive, approximately 40% relaxation to BK was, however, abolished by these treatments. Therefore, neither cytochrome P(450)-derived metabolites of arachidonic acid nor K(+) appear to mediate the EDHF-like relaxation to BK (i.e the non-NO, high K(+)/apamin-sensitive component) in bovine coronary arteries. Cytochrome P(450)-derived metabolites may be released at higher BK concentrations to act in parallel with NO and the high K(+)/apamin-sensitive mechanism.
由于花生四烯酸和钾离子的细胞色素P(450)衍生代谢产物与内皮衍生超极化因子(EDHF)依赖性反应有关,本研究的目的是确定这些因素是否有助于牛离体冠状动脉中除一氧化氮(NO)之外的、内皮依赖性的缓激肽(BK)舒张反应。在用U46619收缩并经吲哚美辛(3 microM)和N(G)-硝基-L-精氨酸(L-NOARG;100 microM)处理的动脉环中,在用高细胞外钾(高K+;15 - 67 mM)或蜂毒明肽(0.3 microM)抑制钾通道后,对BK(0.01 nM - 0.3 microM)的舒张反应被阻断了约60%。哇巴因(1 microM),一种Na(+)/K(+)-ATP酶抑制剂,降低了对BK的敏感性,但不影响最大反应。在L-NOARG处理的动脉环中,哇巴因对BK舒张反应没有进一步影响。内向整流钾通道抑制剂钡离子(30 microM),在不存在或存在L-NOARG或哇巴因的情况下,对BK舒张反应均无影响。氯化钾(2.5 - 10 mM)引起小幅度舒张(约20%),该舒张被硝苯地平(0.3 microM)和哇巴因消除。对BK的高K+/蜂毒明肽敏感的舒张反应以及对钾离子通道开放剂左旋克罗卡林(0.6 microM)的舒张反应,均不受细胞色素P(450)抑制剂7-乙氧基试卤灵(10 microM)影响,也不受与磷脂酶A(2)抑制剂花生四烯酰三氟甲基酮(AACOCF(3);3 microM)和二酰基甘油(DAG)脂肪酶抑制剂1, 6-双-(环己基氧代氨基羰基氨基)-己烷(RHC 80267;30 microM)共同处理的影响。然而,这些处理消除了对BK的非NO/高K+不敏感的约40%的舒张反应。因此,花生四烯酸的细胞色素P(450)衍生代谢产物和钾离子似乎均不介导牛冠状动脉中对BK的类EDHF舒张反应(即非NO、高K+/蜂毒明肽敏感成分)。细胞色素P(450)衍生代谢产物可能在较高BK浓度下释放,与NO和高K+/蜂毒明肽敏感机制协同发挥作用。